BDBM50138231 4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine::CHEMBL113018

SMILES: C(CN1CCOCC1)Oc1ccc(cc1)-n1ccnc1

InChI Key: InChIKey=PXFGMZGVHWPLCC-UHFFFAOYSA-N

Data: 5 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50138231   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cytochrome P450 2C9 (Homo sapiens (Human))	BDBM50138231 (4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...) Show SMILES C(CN1CCOCC1)Oc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C15H19N3O2/c1-3-15(4-2-14(1)18-6-5-16-13-18)20-12-9-17-7-10-19-11-8-17/h1-6,13H,7-12H2	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.81E+3	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2C9				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 1A2 (Homo sapiens (Human))	BDBM50138231 (4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...) Show SMILES C(CN1CCOCC1)Oc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C15H19N3O2/c1-3-15(4-2-14(1)18-6-5-16-13-18)20-12-9-17-7-10-19-11-8-17/h1-6,13H,7-12H2	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.48E+3	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 1A2				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 3A4 (Homo sapiens (Human))	BDBM50138231 (4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...) Show SMILES C(CN1CCOCC1)Oc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C15H19N3O2/c1-3-15(4-2-14(1)18-6-5-16-13-18)20-12-9-17-7-10-19-11-8-17/h1-6,13H,7-12H2	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	5.67E+3	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 3A4				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 2D6 (Homo sapiens (Human))	BDBM50138231 (4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...) Show SMILES C(CN1CCOCC1)Oc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C15H19N3O2/c1-3-15(4-2-14(1)18-6-5-16-13-18)20-12-9-17-7-10-19-11-8-17/h1-6,13H,7-12H2	PDB UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	399	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2D6				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 2C19 (Homo sapiens (Human))	BDBM50138231 (4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...) Show SMILES C(CN1CCOCC1)Oc1ccc(cc1)-n1ccnc1 Show InChI InChI=1S/C15H19N3O2/c1-3-15(4-2-14(1)18-6-5-16-13-18)20-12-9-17-7-10-19-11-8-17/h1-6,13H,7-12H2	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	91	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2C19				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair